Every day, millions of workers step onto construction sites—arguably some of the most hazardous environments in modern ...

Law enforcement officers and emergency medical personnel trained together this week in a high-intensity active shooter drill, working to improve response times and save lives in increasingly ...

SAFETY HARBOR, Fla. — The Philippe Park Living Shoreline project is entering its third phase next month. Pinellas County Emergency Management designed the project to protect the park from ...

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Viridian Therapeutics’ veligrotug has shown one-year durability in a Phase III trial in patients with active thyroid eye ...

A major active travel initiative has transformed the safety and accessibility of Glasgow's Queen's Drive and Langside Road ...

Veligrotug demonstrated strong long-term durability and efficacy in Phase 3 THRIVE trials for thyroid eye disease, meeting ...

Viridian Therapeutics reveals promising long-term results for veligrotug in treating thyroid eye disease, highlighting its ...

Compugen Ltd. (NASDAQ: CGEN) Q1 2025 Earnings Call Transcript May 19, 2025 Compugen Ltd. misses on earnings expectations.

In March, Cingulate released Phase 3 safety data for CTx-1301, demonstrating that the safety profile of CTx-1301 has remained consistent over the course of eight clinical trials. A final analysis that ...

The first patient has received CX-801 plus Keytruda in a phase 1 trial for metastatic melanoma, aiming to assess safety and ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced positive top-line Phase II study results for its novel ...